Bio Pharma Dive
AUGUST 6, 2021
A merger with a blank-check company backed by Casdin Capital will greatly expand the resources available to EQRx, which aims to develop competitors to existing drugs and sell them at "radically lower" prices.
World of DTC Marketing
AUGUST 6, 2021
SUMMARY: The states struggling the most with covid-19 infections also have the least healthy populations. About two out of five American adults are obese, according to the CDC. Mostly because they don’t understand how what they eat effects their health. Only 23% of people get enough exercise and only one in ten eats enough fruit and vegetables, says the CDC.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 6, 2021
There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is currently “middling” it is on the rise, according to a report from IQVIA. The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s acc
Pharma Times
AUGUST 6, 2021
The finalists have been confirmed for the 2021 Clinical Researcher of the Year – The Americas competition.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
AUGUST 6, 2021
Moderna made a massive $4.2 billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around $6 billion from 302 million shots. The tally makes the SpikeVax (mRNA-1273) vaccine the second biggest seller behind Pfizer/BioNTech’s Comirnaty, which pulled in $7.8 billion in the second quarter and $11.3 billion since the start of the year.
XTalks
AUGUST 6, 2021
Each year, International Beer Day rolls around to honor the oldest and most popular alcoholic beverage. This year, it falls on August 6, and unlike many dedicated food and beverage days, the date changes each year to fall on the first Friday of August. So how did International Beer Day come about and how can beer enthusiasts celebrate it? History of International Beer Day.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
FDA Law Blog
AUGUST 6, 2021
By Jeffrey N. Wasserstein & Dara Katcher Levy — We are old enough to remember the “poke” function on Facebook, and too old to remember what purpose it served. We are similarly at a loss to understand the purpose of Facebook’s new policy requiring that pharmaceutical manufacturers, telehealth companies, and online pharmacies apply for permission to advertise on Facebook.
Delveinsight
AUGUST 6, 2021
The treatment options for Non-Small Cell Lung Cancer (NSCLC) have been flooded in recent years due to improved methods of molecular profiling and better diagnostic tools. The new molecular biomarkers with their efficacious treatments for NSCLC have changed the lives of patients where the clinical prognosis was very poor. Some rare biomarkers for NSCLC include METex14 skipping alterations, ALK rearrangements, HER-2 mutations, RET rearrangements, and many more.
Pharma Times
AUGUST 6, 2021
UK Competition and Markets Authority provisionally finds drug companies broke competition law
pharmaphorum
AUGUST 6, 2021
Sanofi and Regeneron’s latecomer checkpoint inhibitor Libtayo has largely been protected from heavyweight competition in its first niche markets, but now looks set to for a toe-to-toe contest with Merck & Co’s class leader Keytruda in the big non-small cell lung cancer (NSCLC) category. Keytruda (pembrolizumab) dominates first-line NSCLC treatment, where it is approved both as a monotherapy and in combination with chemotherapy, but a lengthening list of rivals has been nipping at
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
AUGUST 6, 2021
Libtayo plus platinum-doublet chemotherapy led to a 29% reduction in risk of death compared to chemotherapy alone
Drug Patent Watch
AUGUST 6, 2021
Annual Drug Patent Expirations for RIOMET Riomet is a drug marketed by Ranbaxy and Sun Pharm and is included in two NDAs. It is available from one supplier. There are…. The post New patent expiration for Ranbaxy drug RIOMET appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
AUGUST 6, 2021
Planned Phase II study to combine the BET inhibitor with momelotinib
Drug Patent Watch
AUGUST 6, 2021
Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
AUGUST 6, 2021
Acquisition strengthens Bayer’s drug discovery capabilities
Drug Patent Watch
AUGUST 6, 2021
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-two…. The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
XTalks
AUGUST 6, 2021
In this episode, Sarah talked about attending the Alzheimer’s Association International Conference (AAIC) 2021 virtually this year and discussed increasing diversity in Alzheimer’s clinical trials as an important topic that was part of the conference. Black and Hispanic people are more likely to be diagnosed with Alzheimer’s compared to Caucasians. Sarah outlined the results of some studies shared at the meeting, including a study that revealed people of minority backgrounds would be more likely
Drug Patent Watch
AUGUST 6, 2021
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Clinical Trial Gurus
AUGUST 6, 2021
Prospective clinical research site owners likely have many things on their minds. This video attempts to distill the key components that in my opinion are lesser discussed or under-appreciated.
Drug Patent Watch
AUGUST 6, 2021
Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. There are eleven patents protecting this drug. Drug patent…. The post New patent for Baxter Hlthcare drug NOURESS appeared first on DrugPatentWatch - Make Better Decisions.
Cloudbyz
AUGUST 6, 2021
Medhealth Outlook has included Cloudbyz in its list of top ten clinical trial management solution providers for 2020. Medhealth Outlook has come up with the list after a careful and comprehensive assessment by its team of CEOs, industry experts, editorial board, and analysts. The list of “10 Most Promising Clinical Trial Management Solution Providers” offers clear insight into the applications of different solutions.
BioTech 365
AUGUST 6, 2021
BioVie Inc. Announces Proposed Public Offering of Common Stock BioVie Inc. Announces Proposed Public Offering of Common Stock SANTA MONICA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) — BioVie Inc.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
AUGUST 6, 2021
Gilead Sciences’ Kite Pharma has mapped out another route to the development of allogeneic or ‘off-the-shelf’ cell therapies for cancer, using technology developed by Appia Bio, a US startup focusing on haematopoietic stem cells (HSCs). The partnership will combine Kite’s experience in chimeric antigen receptor (CAR) therapies with Appia’s platform, which involves using HSCs to form invariant natural killer T cells (iNKT), a type of T cell that attacks malignant cel
BioTech 365
AUGUST 6, 2021
atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V.
Drug Patent Watch
AUGUST 6, 2021
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Bulgaria? appeared first on DrugPatentWatch - Make Better Decisions.
BioTech 365
AUGUST 6, 2021
Adventure Dental Vision and Orthodontics to Offer Back to School Dental and Vision Appointments in Correlation With School Supply Distribution on August 7th Adventure Dental Vision and Orthodontics to Offer Back to School Dental and Vision Appointments in Correlation With … Continue reading →
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Intouch Solutions
AUGUST 6, 2021
So … you’re thinking about interning with Intouch. Or, at least, that’s why I initially stumbled upon Intouch’s blog earlier this year. I was hungry for information about a company I had never heard about before but was considering taking an internship with. Now, several months later, I’m so glad I did. But let’s back up. Regardless of what brought you to this blog post, you’re about to hear all about what Intouch’s remote summer internship program was like from me, Daphne, an intern in Intouch’
BioTech 365
AUGUST 6, 2021
Immunovant to Report Financial Results for Quarter Ended June 30, 2021 Immunovant to Report Financial Results for Quarter Ended June 30, 2021 NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc.
BioTech 365
AUGUST 6, 2021
Kids and Teen Dental Place and UCLA School of Dentistry Partner With Drew Child Development Corporation to Provide 1,000 Free Fluoride Treatments at Back to School Event on August 7th Kids and Teen Dental Place and UCLA School of Dentistry … Continue reading →
BioTech 365
AUGUST 6, 2021
Valor Compounding Pharmacy™ Will Be Featured on Fox Business Network on Sunday, August 8, 2021, at 5:30 pm EDT Valor Compounding Pharmacy™ Will Be Featured on Fox Business Network on Sunday, August 8, 2021, at 5:30 pm EDT Worldwide Business … Continue reading →
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
325 
Let's personalize your content